Diverse functions of the homeodomain transcription factor BARX1 include Wnt-dependent, non-cell autonomous specification of the stomach epithelium, tracheo-bronchial septation, and Wnt-independent expansion of the spleen primordium. Tight spatio-temporal regulation of Barx1 levels in the mesentery and stomach mesenchyme suggests additional roles. To determine these functions, we forced constitutive BARX1 expression in the Bapx1 expression domain, which includes the mesentery and intestinal mesenchyme, and also examined Barx1 À / À embryos in further detail. Transgenic embryos invariably showed intestinal truncation and malrotation, in part reflecting abnormal left-right patterning. Ectopic BARX1 expression did not affect intestinal epithelium, but intestinal smooth muscle developed with features typical of the stomach wall. BARX1, which is normally restricted to the developing stomach, drives robust smooth muscle expansion in this organ by promoting proliferation of myogenic progenitors at the expense of other sub-epithelial cells. Undifferentiated embryonic stomach and intestinal mesenchyme showed modest differences in mRNA expression and BARX1 was sufficient to induce much of the stomach profile in intestinal cells. However, limited binding at cis-regulatory sites implies that BARX1 may act principally through other transcription factors. Genes expressed ectopically in BARX1 þ intestinal mesenchyme and reduced in Barx1 À / À stomach mesenchyme include Isl1, Pitx1, Six2 and Pitx2, transcription factors known to control left-right patterning and influence smooth muscle development. The sum of evidence suggests that potent BARX1 functions in intestinal rotation and stomach myogenesis occur through this small group of intermediary transcription factors.
Introduction
Anterior-posterior patterning of the embryonic gut in vertebrate animals produces digestive organs-the esophagus, stomach, and intestines-with characteristic epithelial, sub-epithelial, and mural features. Region-specific interactions between the endoderm-derived epithelium and adjacent mesoderm-derived mesenchyme drive this patterning and depend on transcription factors (TFs) that are expressed in restricted domains (Spence et al., 2011) . Among such TFs, expression of the homeodomain protein BARX1 is limited to the esophageal and stomach mesenchyme and required for proper development of both organs (Kim et al., 2005; 2007; Woo et al., 2011) . In ex vivo cultures, loss of BARX1 from fetal mouse stomach mesenchyme has a non-cell autonomous effect on overlying endoderm, inducing epithelium with intestinal instead of stomach markers (Kim et al., 2005) .
Barx1 À / À mouse embryos have a small, dysmorphic foregut with a trachea-esophageal fistula (Woo et al., 2011) and a stomach epithelium replaced by villous, intestine-type mucosa (Kim et al., 2005; 2007) . Both these anomalies reflect unchecked Wnt signaling owing to reduced mesenchymal production of the Wnt antagonists SFRP1 and SFRP2 (Kim et al., 2005; Woo et al., 2011) . Barx1 is also expressed in the spleen anlage, which arises adjacent to the stomach, and although the Barx1 À / À spleen is miniscule, this defect is unrelated to SFRPs or Wnt signaling (Kim et al., 2007) . Thus, BARX1 helps pattern the mammalian foregut, in part through local inhibition of Wnt signaling, and has Wnt-independent requirements in spleen development.
Other important aspects of Barx1 function and mechanisms remain unknown: Does the non-cell autonomous effect on overlying gut endoderm force stomach differentiation or merely avoid the intestinal fate? Is induction of stomach-type epithelium its predominant function or does BARX1 have additional, cell-autonomous requirements in foregut mesenchyme? In addition to the stomach wall, Barx1 is expressed in portions of the mesentery, the loose mesoderm-derived membrane that attaches bowel loops to each other and to the dorsal body wall. Barx1's role in spleen development seems related to this mesenteric expression (Kim et al., 2007 ) but its precise expression domain and additional functions are not known.
To address these questions, we forced BARX1 expression in mouse intestinal mesenchyme and the mesentery at levels similar to those present in the native fetal stomach. Ectopic BARX1 expression did not perturb the stomach-intestine boundary or epithelial differentiation, but produced profound cell-autonomous defects in enteric myogenesis and gut rotation. We find that in embryonic gut mesenchyme, BARX1 promotes proliferation of muscle cell progenitors at the expense of non-muscle cells; in the mesentery, it controls the gut rotation that is necessary to reverse the physiologic umbilical hernia. To determine the basis for these developmental functions, we identified embryonic genes that respond to BARX1 in the intestine and depend on BARX1 for expression in the stomach. Our studies suggest that both functions occur through a select group of intermediary transcription factors (TFs), including Pitx2 and Isl1, TFs previously implicated in organ laterality and muscle differentiation. Data from BARX1-overexpressing and Barx1 À /À embryos corroborated these conclusions. Thus, this study identifies new and distinct roles for BARX1 in abdominal organogenesis and patterning, and reveals key TF targets that likely drive organ positioning and tissue differentiation.
Materials and methods
Mice. To generate Cre-activated Barx1 Int mice, we inserted a LoxP-flanked Neo R stop cassette and Barx1 cDNA ( Fig. 1A ) into pROSA26-1 (Zambrowicz et al., 1997) , electroporated JM8 ES cells with the resulting targeting construct, and screened ES cell clones by Southern blotting to identify homologous recombinants. We verified correct targeting at the 5' end by PCR ( Fig. 1B) using primers complementary to exon 1 of Rosa26 (CCTAAAGAA-GAGGCTGTGCTTTGG) and the Neo r cassette (TGAATGAACTGCAG-GACGAGGCAG), which yield a 2040-bp product. At the 3' end, primers complementary to Barx1 (AGCCTCGACTGTGCCTTCTA) and exon 2 of Rosa26 (TGTTCAAGCAGGACCAAATGTG) yielded a 4775bp product. Transgenic mice were subsequently genotyped by PCR ( Fig. 1B) using a common forward primer in intron 1 of Rosa26 (GAGTTCTCTGCTGCCTCCTG), with reverse primers in this intron to amplify a 600-bp product G-C from the untargeted allele (GCCAATGCTCTGTCTAGGGG) or 3' to the proximal LoxP site to amplify a 320-bp product G-M from the targeted allele (GTTCTTCTGAGGGGATCGGC). Bapx1-Cre (Verzi et al., 2009) , Rosa26 YFP (Srinivas et al., 2001) , and Barx1-null (Kim et al., 2005) mice were described previously. We regarded the morning of a vaginal plug as embryonic day (E) 0.5. Animal care and procedures were approved and monitored by an Institutional Animal Care and Use Committee.
Histology, histochemistry, immunostaining, and microscopy. Whole embryos younger than E14.5 or isolated digestive tracts from older embryos were fixed overnight at 4 1C in 4% paraformaldehyde in phosphate-buffered saline (PBS), washed in PBS, and either frozen in OCT compound (Sakura) to detect YFP expression or dehydrated in ethanol and embedded in paraffin for other analyzes. Ten-μm frozen tissue sections were washed in PBS, stained with DAPI (Vectashield Mounting Media), and examined under a fluorescent microscope or 5-to 6-μm paraffin tissue sections were stained with Hematoxylin and Eosin, Alcian Blue, Periodic Acid Schiff, or Alkaline Phosphatase substrate, or with antibodies (Ab) to BARX1 (Kim et al., 2007) (1:1000), PDX1 (gift of Christopher Wright, Vanderbilt University) (1:1000), SMA-A (Biogenex, 1:300), Ki67 (Thermo Fisher, 1:1000), H/K ATPase (MBL, 1:1000), Pepsinogen (Abcam, 1:1000), or CDX2 (Biogenex, 1:200). Horseradish peroxidase-conjugated secondary Ab (Vector Laboratories) were applied at 1:5000 dilution. Reactions were developed using DAB substrate (Sigma) and slides were counterstained with hematoxylin. The widths of intestinal villi at their base and thickness of circular smooth muscle were measured in transverse tissue sections using ImageJ tools (http://imagej.nih.gov/ij/). Fiveμm sections of E17.5 tissues were co-stained on the same slides with SMA-A and Ki67 Ab, followed by FITC-or Cy3-conjugated secondary Ab (Jackson Laboratories, 1:1000). Vectashield mounting media with DAPI (Vector Laboratories) was added prior to imaging at least 6 separate fields in 3 biologic replicates. DAPI þ and Ki67þ nuclei were counted in SMAþ and SMA-sub-epithelium using the Cell Counter plug-in feature in ImageJ (http:// imagej.nih.gov/ij/). Histologic comparisons were made between the same regions of the proximal intestine in wild-type and mutant mice. We measured villus width, muscle thickness, and muscle cell fractions in multiple sections of the same regions in control and mutant samples.
Tissue isolation and cell culture. For intestinal and stomach mesenchyme, organs isolated from E13.5 or E17.5 mouse embryos were washed in cold Hank's Buffered Saline Solution (HBSS, Invitrogen) and digested sequentially in 0.1% Collagenase-Dispase (Roche) in HBSS at 37 1C for 30 min and 0.25% Trypsin-EDTA (Invitrogen) at 37 1C for 10 min. Cells were harvested by centrifugation, cultured in Dulbecco's Modified Eagle Medium (Invitrogen) supplemented with glutamine, 20% fetal bovine serum and 1% Penicillin-Streptomycin, and analyzed after a 3-day period in which endodermal derivatives die and highly enriched mesenchyme remains (Kim et al., 2005) . E17.5 mesentery was dissected from the whole intestine under microscope guidance and processed immediately for RNA extraction.
Gene expression analyses. Tissues were homogenized in TRIzol reagent (Invitrogen) using a rotor homogenizer, snap frozen, and stored at À 80 1C. RNA was isolated with RNeasy mini-kits (QIA-GEN), treated with DNaseI, and reverse transcribed using the Superscript III First-Strand Synthesis System (Invitrogen). For quantitative RT-PCR we used FastStart Universal SYBR Green Master Mix (Roche) and gene-specific primers (Suppl. Table 3 ).
Relative mRNA levels were determined using the ΔΔC T method (Livak and Schmittgen, 2001) , with normalization to the levels of Hprt mRNA. Graphing and statistical analyzes were performed using GraphPad Prism 6.0 software and P-values were calculated using unpaired t tests. For transcriptome analyzes, RNA was hybridized to Mouse Genome 430A v2.0 arrays (Affymetrix) and data were analyzed in Gene Pattern (http://genepattern.org) using the Expression File Creator (RMA normalization), Comparative Marker Selection, Principal Component Analysis, and Hierarchical Clustering tools. Data are deposited in the Gene Expression Omnibus (GSE ID: 69483). Barx1 mRNA in situ hybridization was described previously (Kim et al., 2005) .
Chromatin immunoprecipitation (ChIP), sequencing, and analysis. We inserted Barx1 cDNA with 3 tandem FLAG epitopes immediately after Egfp cDNA and P2A cleavage sequences in pUltra and used this construct to produce 3xFlag-Barx1 lentivirus in 293FT cells. This virus was used to infect E13.5 mouse embryonic stomach mesenchymal cells immortalized by expression of a dominant-negative TRP53 mutant, p53DD (Shaulian et al., 1992) . Infected cells were monitored for EGFP expression over 7 days of expansion, then cross-linked with 1.1% formaldehyde in PBS for 10 min at room temperature before nuclei were extracted in a hypotonic buffer (50 mM Tris-HCl, pH 8.0, 85 mM KCl, 0.5% NP-40). Extracts were sonicated (50 mM Tris-HCl, pH 8.1, 10 mM EDTA, 0.1% SDS) to obtain 200-to 500-bp DNA fragments and immunoprecipitated as described previously (Verzi et al., 2010) using 10 μg Flag-M2 Ab (Sigma) and Protein G Dynabeads (Invitrogen). Libraries from the input (sonicated DNA) and ChIP material were prepared using ThruPlex kits (Rubicon Genomics) and sequenced on the Illumina platform. Data are deposited in the Black dashed lines demarcate borders between the epithelium and mesenchyme. All scale bars, 50 μm.
Gene Expression Omnibus (GSE ID: 69483). BARX1 binding sites were identified using Model-Based Analysis of ChIP-Seq (MACS2) with a q-value cutoff of 0.1 and analyzed using tools in Cistrome (http://cistrome.org/ap/).
Results

Targeted ectopic expression of Barx1 in mouse intestinal mesenchyme and mesentery
We used homologous recombination in embryonic stem (ES) cells to insert inducible Barx1 cDNA into the Rosa26 locus. The targeting construct contained a splice-acceptor sequence and a LoxP-flanked Neomycin resistance (Neo R ) stop cassette upstream of Barx1 cDNA (Fig. 1A) , to allow Cre-mediated excision of the stop cassette and transgene expression from the targeted Rosa26 (L-S-L)Barx1 allele (Rosa26 Bx ). We activated Barx1 expression using Bapx1 Cre mice, which express Cre recombinase in several abdominal structures, including the mesenchyme of the gastric antrum and of the whole intestine, by E9.5 (Verzi et al., 2009 ). Bapx1 þ /Cre ;Rosa26 (L-S-L)YFP mouse embryos indicated Cre-activated YFP reporter expression throughout the E13.5 intestinal submucosa, including the lamina propria and smooth muscle (Fig. 1C ). Importantly, YFP expression extended to the outermost cell layer, the serosa, which is contiguous with the mesentery (arrowheads in Fig. 1C , inset). We expected Bapx1 þ /Cre ;Rosa26 þ /Bx (henceforth celled Barx1 Int ) mice to express Barx1 in the same domain, and indeed, mRNA levels in E13.5 Barx1 Int intestines were comparable to those in wild-type stomachs and 100 times higher than the levels in wild-type intestines (Fig. 1D ). Because Creinduced deletion of the stop cassette is stably transmitted to all cellular progeny, expression was sustained at E17.5. Immunohistochemistry showed ectopic BARX1 in the intestinal mesenchyme but not in endoderm-derived mucosal cells ( Fig. 1E-H) . Unlike the stomach, where Barx1 levels decline significantly after E13.5 (Kim et al., 2005) , the protein persisted in E17.5 intestinal mesenchyme, as expected ( Fig. 1H ).
Ectopic BARX1 expression produces severe defects in development of the alimentary canal and other abdominal organs
Barx1 Int mice died immediately after birth ( Fig. 2A ). In crosses between Rosa26 þ /Bx and Bapx1 þ /Cre parents, however, Barx1 Int embryos were present in the correct Mendelian ratios at E13.5 and E17.5, with complete penetrance of defects, such as gastroschisis, which explain neonatal lethality. The physiologic umbilical hernia, which normally reverses by E15, persisted in Barx1 Int embryos: a portion of the intestine, including the cecum, invariably lay outside a perforated abdominal wall (Fig. 2B ). The small intestine, but not the colon, was markedly reduced in length ( Fig. 2C-E) . In normal mice, the duodenum first extends away from the stomach before turning 1801 (Savin et al., 2011) to encompass the pancreas within the resulting loop ( Fig. 2D ). In Barx1 Int embryos, by contrast, the duodenum was fully apposed to the greater curvature of the stomach, having turned sharply leftward and posteriorly at the pyloric junction ( Fig. 2C ,D,F), nearly identical to the reported effect of forced symmetry in visceral Pitx2 expression (Shiratori et al., 2006) . In addition, all Barx1 Int embryos lacked a spleen ( Fig. 2D ) and the pancreas was hypoplastic ( Fig. 2D ) and mispositioned ( Fig. 2F-G) . A diminutive pancreas was always present in a narrow pocket between the greater curvature of the stomach and the malrotated duodenum ( Fig. 2G ). Thus, ectopic BARX1 affected the development of abdominal organs profoundly and in a consistent manner.
The mean proportional reduction in small intestine length, measured from pylorus to cecum, was similar at E13.5 at E17.5 ( Fig. 2E) . Similarly, pancreas defects were evident by E13.5 (Fig. 2F) ; the gastric antrum, pancreas, and duodenal wall had fused by E14.5 (Fig. 2G) ; and a spleen was never present. Thus, defects in abdominal organ size and form appeared soon after forced BARX1 expression. In the most overtly affected organ, the intestine, Barx1 is normally expressed transiently and only in the mesentery (Kim et al., 2005) . Therefore, these findings suggest that physiologic attenuation of mesenteric Barx1 levels is necessary for proper intestinal rotation and length. Notably, absence (Kim et al., 2007) or ectopic expression ( Fig. 2D ) of BARX1 result in reduced spleen mass and asplenia, respectively, revealing that the spleen anlage is extremely sensitive to the amount or duration of Barx1 expression.
Intestinal BARX1 expression preserves epithelial identity
BARX1 expression in embryonic stomach mesenchyme helps specify the overlying gastric epithelium by E13 (Kim et al., 2005; 2007) . If this activity represents a dominant, context-independent function, then Barx1 Int intestines might show stomach features, especially because they sustain BARX1 expression from an early time. These intestines did not, however, express markers of any gastric lineage: H þ /K þ ATPase (Atp4b), Pepsinogen, or strong surface affinity for Periodic Acid Schiff ( Fig. 3A-C ). Other gastric markers were undetectable even by qRT-PCR ( Fig. 3D) ; only Gastrin, a hormonal gene normally expressed in stomach and duodenal epithelia, was elevated in Barx1 Int intestines (Fig. 3D ). CDX2, an intestine-specific transcription factor, was robustly expressed in E12.5 and older Barx1 Int intestines ( Fig. 3E and F) , which showed normal proportions of Alcian blue-avid goblet cells ( Fig. 3G ) and alkaline phosphatase-expressing enterocytes (Fig. 3H) , and normal levels of intervillus cell proliferation ( Fig. 3I ). Thus, unlike BARX1's potent role in the stomach, it is insufficient to impose stomach differentiation on intestinal endoderm, even with timing and levels of ectopic expression similar to those in the native stomach. In en face views of whole-mount intestines, however, some Barx1 Int villus profiles appeared abnormally wide ( Fig. 3J and K) and close inspection of transverse sections (Suppl. Fig. 1A ) supported this observation. Measurements at the villus base confirmed a small but statistically significant increase in average villus width (Fig. 3L ). We conclude that Barx1's role in patterning the digestive epithelium is confined to the prospective stomach and that ectopic intestinal expression produces a subtle defect in villus morphology.
BARX1 induces smooth muscle of a stomach type in the intestine
Stomach smooth muscle is bulky, with thick bundles of alphasmooth muscle actin (SMA-A) expressing cells in the wall and thick interstitial smooth muscle (muscularis mucosae) present in the lamina propria (Fig. 4A ). Normal intestinal muscle has notably less mass and the lamina propria contains a single layer of myofibroblast cells with limited contractility (Powell et al., 2011) . These differences in enteric muscles underlie distinct digestive functionsmechanical disruption of food in the stomach and peristaltic propulsion of intestinal luminal contentsbut the molecular basis for differential myogenesis is unknown. Unexpectedly, intestinal smooth muscle in Barx1 Int mice showed a distinctly gastric character, with thick bundles in the wall and bulky interstitial fibers (Fig. 4A) . Smooth muscle was expanded throughout the intestinal length and uniformly around the perimeter (Fig. 4B) , with some areas of additional focal hypertrophy (Fig. 4C ).
Smooth muscle was absent from the pancreas, where minimal SMA-A staining in the parenchyma was similar to that in control samples and contrasted sharply with strong, uniform staining in the adjoining intestinal wall (Fig. 4D ). We detected no hypertrophy of smooth muscle in the gastric pylorus (Suppl. Fig. 1C) , where abnormal turning of viscera at the gastro-duodenal junction (Figs. 2D, 2G ) precluded strict comparison of the valvular structure with control animals.
We had previously noted patchy musculature in Barx1 À / À stomachs (Kim et al., 2007) , but the significance of this finding in the diminutive mutant organ had been unclear. In light of the smooth muscle abnormalities in Barx1 Int intestines, we measured expression of myogenic differentiation markers in both settings. Genes with increased mRNA levels in Barx1 Int intestines showed reduced levels in Barx1 À / À stomachs, compared to age-matched wild-type littermates, (Fig. 4E) . Thus, both gain-and loss-offunction studies support a profound, cell-autonomous effect on enteric smooth muscle development. Smooth muscle, which was equally thin in the proximal and distal small intestine in control embryos, was uniformly thickened along the whole small intestine in Barx1 Int mice and most evident in the inner circular layer and interstitium; the outer layer of longitudinal smooth muscle was too flat to reveal differences from wild-type intestines. Circular smooth muscle thickness was similar to that in wild-type intestines at E14.5 and increased steadily thereafter, with near doubling by E17.5 (Fig. 4F ).
This progression (Fig. 4G-I) implies either that muscle progenitors had expanded after mid-gestation or that undifferentiated sub-epithelial mesenchymal cells had adopted the muscle fate. To distinguish between these possibilities, we examined SMA and Ki67 expression (stained with different colors on the same sections) in wild-type stomach and intestine, Barx1 Int intestines, and Barx1 À / À stomachs (Fig. 5A-D) . We defined muscle cells as SMA þ cells with DAPI-stained nuclei; non-muscle cells as subepithelial DAPI þ cells lacking SMA; and proliferating cells as those expressing Ki67. Compared to wild-type tissues, Barx1 Int intestines (Fig. 5B,C,E) and Barx1 À / À stomachs (Fig. 5A,D,E) showed significantly expanded and depleted smooth muscle compartments, respectively. Moreover, Barx1 Int intestines showed increased proliferation of muscle, and reduced proliferation of non-muscle, cells compared to wild-type littermates (Fig. 5F) . By contrast, Barx1 À / À stomachs showed reduced muscle cell, and increased non-muscle cell, proliferation. Thus, in the enteric wall, BARX1 promotes muscle cell proliferation at the expense of non-muscle cells. In (L) Small increase in average intestinal villus width in Barx1 Int intestines, measured in transverse sections of the duodenum (n ¼3 for each genotype). All scale bars, 50 μm. contrast to its cell-nonautonomous role in specifying stomach epithelium, this effect in a BARX1-expressing tissue in wild-type and Barx1 Int mice is likely cell-autonomous.
Molecular basis of BARX1-dependent gastric myogenesis and visceral laterality
The smooth muscle expansion in Barx1 Int intestines resembles defects observed in Xenopus tadpoles with impaired enteric Hedgehog (Hh) signaling (Zhang et al., 2000) . Hh signaling also profoundly influences mouse gut myogenesis (Kosinski et al., 2010; Mao et al., 2010; Ramalho-Santos et al., 2000; Zacharias et al., 2011b) and enteric muscle in chick embryos responds to a gradient of endoderm-derived Hh ligands (Sukegawa et al., 2000) . Thus, amplified Hh effects on smooth muscle differentiation in the native stomach could potentially explain the excess muscle in Barx1 Int intestines. However, well-validated markers of Hh signaling were not altered (Suppl. Fig. 1B) . These data argue against defective Hh signaling in enteric muscle development and in favor of possible cell-autonomous BARX1 functions.
To identify other potential determinants, we isolated mesenchyme from wild-type stomach and intestine and from Barx1 Int intestine at E13.5, after forced BARX1 expression but before development of muscle hypertrophy. We cultured cells for 3 days to deplete endoderm (Kim et al., 2005) and used microarrays to evaluate mRNA expression in highly enriched mesenchymal cells. Principal component analysis (Fig. 6A ) and unsupervised hierarchical clustering (Fig. 6B ) revealed that expression profiles in Barx1 Int intestinal mesenchyme resembled wild-type stomach about as much as they did wild-type intestinal mesenchyme. Importantly, fewer than 200 genes showed significantly different levels in wild-type embryonic stomach and intestinal mesenchyme (Suppl. Table 1) and many transcripts that changed in Barx1 Int intestinal mesenchyme (Suppl. Table 2) corresponded to these differentially expressed genes (Fig. 6C ). Nearly 2/3 of genes activated in Barx1 Int mesenchyme are selectively expressed in wild-type stomach mesenchyme and 2/3 of intestine-selective genes were reduced in Barx1 Int intestinal mesenchyme (Fig. 6D) . These observations implicate BARX1 as a crucial determinant of stomach mesenchyme, accounting for much of the difference from its intestinal counterpart.
This expression analysis confirmed absence of changes in Hhdependent or Hh-effector genes in Barx1 Int mesenchyme (data not shown) and few cardinal myogenic regulatory genes were dysregulated at E13.5, before notable muscle expansion. Moreover, we detected few overall transcriptional changes, even though ectopic BARX1 expression leads to substantive later defects and even though most TFs regulate hundreds of genes (Biggin, 2011) . To consider the possibility that BARX1 controls few genes directly, and myogenesis or other developmental functions indirectly, we used chromatin immunoprecipitation (ChIP) to map its cistrome. As available BARX1 Ab perform poorly in ChIP, we expressed FLAG epitope-tagged BARX1 in immortalized E13.5 mouse embryonic stomach mesenchymal cells (Fig. 6E) and used FLAG Ab for ChIP. In agreement with the few transcripts affected by BARX1 in vivo, we identified only 294 sites of BARX1 occupancy (false discovery rate, qo 0.1), which contrasted sharply with the $ 10,000 binding sites we had identified separately for FLAG-tagged ATOH1 in adult intestinal crypt cells (Kim et al., 2014) . These 294 sites showed phylogenetic conservation, indicating bona fide cis-regulatory elements, and the BARX1 consensus sequence was the most highly enriched motif, which implies direct TF binding ( Fig. 6F and G) . Moreover, we detected strong binding at the Barx1 locus - suggesting autoregulation, a common feature of developmental TFs (Davidson, 2006 )and near several other genes (e.g., Pgk1 and Usp1 promoters, Fig. 6H ). As most BARX1 binding occurs far from gene bodies, it is difficult to assign binding sites confidently to specific genes (Suppl . Table 3 lists all genes located within 100 kb of BARX1 binding), but very few genes with altered RNA expression in Barx1 Int mesenchyme showed nearby binding. Together, these observations suggest that BARX1 may execute many of its functions indirectly, acting through intermediary factors.
Indeed, the largest category of differentially expressed genes in Barx1 Int intestines, and the one with expression changes of the highest magnitude, encodes TFs with known roles in development (Fig. 7A , Suppl. Table 1) ; such TFs are ideal candidates for an intermediary role. Six2 in particular has important functions in myogenesis, acting upstream of Myod (Relaix et al., 2013a) , with a well-defined requirement in forming distal stomach muscle (Self et al., 2009 ) and Pitx2 controls extra-ocular myogenesis (Zacharias et al., 2011a) . Isl1 and Pitx2 are further implicated in abdominal laterality; both TFs are restricted to the left side and a complementary factor, Tbx18, is confined to the right side Kurpios et al., 2008; Logan et al., 1998; Ryan et al., 1998) . qRT-PCR analysis of fresh isolates of E13.5 mesenchymal cells revealed 10-to 4100-fold higher levels of each TF mRNA in wildtype stomach, relative to the intestine, and comparable elevations in Barx1 Int intestinal mesenchyme (Fig. 7B) . In purified E17.5 stomach mesenchymal cells, many TF genes returned to the low levels found in the intestine, whereas Pitx1 and Six2 mRNAs remained high (3.5-to 20-fold), though far less than in E13.5 stomach (4100-fold). However, all these TF mRNAs remained elevated in E17.5 Barx1 Int intestinal mesenchyme, in parallel with Barx1 (Fig. 7B ). Thus, BARX1 may act primarily by controlling TF genes, such as Isl1, Pitx1, Pitx2 and Six2. As asymmetries in the abdominal mesentery underlie fetal intestinal rotation Kurpios et al., 2008) and the visceral looping defect in Barx1 Int embryos closely resembles that reported in mice with enforced symmetry of Pitx2 expression (Shiratori et al., 2006) , we asked next if these putative secondary TFs might plausibly mediate the completely penetrant gut malrotation seen in Barx1 Int embryos. The domain of Barx1 mRNA in wild-type E10.5 (Fig. 7C top left) and E11.5 (Fig. 7C bottom right) mesentery is markedly asymmetric: expression is confined to the left side, contiguous with the splanchnic mesenchyme and extending toward the proximal intestine on the left side (red arrows in Fig. 7C bottom right) , but not to distal loops on the right. This domain overlaps both with that of Isl1 and Pitx2 mRNAs Kurpios et al., 2008) and with the site of invariable fusion of the duodenum to the stomach wall in Barx1 Int embryos (Fig. 2D,F,G) . Moreover, elevated Barx1 mRNA in Barx1 Int mesentery, expected because Bapx1-Cre is expressed in the mesentery, was associated with elevated levels of Pitx2 and especially Isl1 mRNAs (Fig. 7D) . Moreover, elevated levels of Tbx18 in isolated whole mesentery (Fig. 7D) indicated disrupted left-right patterning. Together, these findings support a model in which BARX1 controls expression of other tissue-restricted TF genes in the stomach mesenchyme and in mesentery on the left side.
Discussion
This study extends understanding of the roles and mechanisms of a pivotal developmental regulator, Barx1, beyond its previously established function in specifying the stomach epithelium and expanding the spleen. By investigating the results of forced Barx1 expression in the Bapx1 domain, together with reanalysis of Barx1 À / À embryos, we uncovered additional activities in stomach myogenesis and intestinal rotation. Thick, well-developed smooth muscle is a cardinal feature of the stomach, distinct from the delicate intestinal musculature, and is necessary for the mechanical breakdown of solid foods. Barx1 Int intestines showed histologic features of stomach muscle and increased proliferation of muscle progenitors, whereas Barx1 À / À stomachs showed reduced proliferation and numbers of smooth muscle cells. Thus, Barx1 promotes stomach muscle at the expense of other mesenchymal cells, an activity that seems to account for the principal differences between gastric and intestinal muscle. Although Barx1 loss induced epithelium of an intestinal type in the stomach (Kim et al., 2005) , ectopic Barx1 expression in intestinal mesenchyme did not perturb epithelial differentiation significantly, with discernible defects limited to a subtle widening of intestinal villi (Fig. 3 ). An important role for enteric smooth muscle was recently proposed in villus morphogenesis (Shyer et al., 2013) and the villus defect in Barx1 Int intestines may well represent a consequence of excess underlying muscle. Additionally, ectopic BARX1 expression invariably resulted in significant shortening of the intestine, for unclear reasons. We conclude that stomach mucosal features are not an inevitable consequence of Barx1 expression in the underlying mesenchyme, but reflect the outcome of specific tissue interactions in the anterior foregut. In wild-type mid-gestation embryos, Barx1 is transiently expressed at high levels in stomach mesenchymal cells and the mesentery, but is excluded from endoderm; its effects on epithelial differentiation are therefore indirect. By contrast, the effects on myogenesis occur in Barx1 þ mesenchymal cells, revealing cell-autonomous activity in gastric smooth muscle development.
In addition to foregut mesenchyme, Barx1 is expressed transiently in the left mesentery, contiguous with splanchnic mesenchyme, and our study revealed unexpected consequences of sustained, likely symmetric Barx1 activity in this abdominal structure. Highly penetrant anomalies in Barx1 Int embryos included gastroschisis, intestinal and pancreatic hypoplasia, and asplenia (Fig. 2) ; in contrast, Barx1 À / À embryos have a hypoplastic spleen containing the correct cell complement (Kim et al., 2007) . As recent work reveals an instructive role for Wnt signaling and Pitx2 in development of abdominal wall muscles and closure of the ventral body wall (Zhang et al., 2014) , prominent gastroschisis in Barx1 Int embryos ( Fig. 2B and C) could be a direct consequence of Barx1's known inhibition of Wnt signaling in other abdominal tissues (Kim et al., 2005; 2007; Woo et al., 2011) . Alternatively, gastrochisis may be an indirect consequence of gut malrotation. Because intestinal rotation is known to depend on asymmetries in the dorsal mesentery Kurpios et al., 2008) , where ectopic BARX1 disturbs expression of key TF genes (Fig. 7) , we attribute the gut malrotation and associated gastro-duodenal fusion in Barx1 Int mice to gene dysregulation in the early dorsal mesentery.
It is surprising, in this light, that an excess of BARX1 affected only a few dozen genes in gut mesenchymal cells. However, wildtype E13.5 stomach and intestinal mesenchyme also differed little in transcript profiles and ectopic Barx1 was sufficient to drive much of the stomach-specific transcriptional program in intestinal mesenchyme. The most notable component of this program is a handful of TF genes, including Pitx2, Isl1 and Six2, that can together account for the diverse developmental consequences. Expression of each of these putative target and effector genes parallels that of Barx1 in wild-type, Barx1 Int and Barx1 À / À mesenchyme and in Barx1 Int mesentery. Although we did not detect BARX1 occupancy within 50 kb of these TF genes, our experiments in cultured stomach mesenchymal cells may have captured only part of the full cistrome or BARX1 may activate them from a greater distance or indirectly. Nevertheless, these TFs are ideal candidate mediators of crucial Barx1 activity because they are independently implicated in each of these functions. Isl1 þ progenitor cells differentiate into smooth muscle in other tissues (Moretti et al., 2006) . Levels of Pitx1 and Pitx2 rise during myogenesis and both TFs enhance myogenic differentiation in satellite cell-derived myoblasts (Knopp et al., 2013) . Six-family proteins activate MyoD and control myogenesis (Relaix et al., 2013b) , with a particular role for Six2 in forming gastric pyloric muscle (Self et al., 2009) . Pitx2 and Isl1 also determine L-R abdominal asymmetry and drive intestinal rotation Kurpios et al., 2008) , and the duodenal malrotation seen in Barx1 Int embryos is very similar to the defect that occurs when Pitx2 expression is symmetric (Shiratori et al., 2006) .
Conclusions
The sum of defects in Barx1 Int and Barx1 À / À embryo reveals this homeodomain TF's potent role in patterning the abdominal organs. Our findings suggest that diverse BARX1 functions in different cells occur through a core group of intermediary TFs. In wild-type mesentery, BARX1-regulated asymmetric expression of Pitx2 and Isl1 enables proper intestinal rotation. BARX1 activates the same secondary TFs, and others such as Six2, in the stomach mesenchyme, leading to the characteristic differences between intestinal and gastric smooth muscle. hybridization; Warren Zimmer for the gift of Bapx1 Cre mice; William Hahn for providing a p53DD plasmid; Christopher Wright for PDX1 antiserum; and Unmesh Jadhav, Kazu Murata, Maddie Saxena and Adrianna San Roman for helping complete experiments during manuscript revision.
